| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Clostridium chauvoei - septicum - novyi - sordellii - pasteurella haemolytica - multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mink distemper - enteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Feline panleukopenia vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Leptospira canicola bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Equine rhinopneumonitis - influenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Moraxella bovis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Transmissible gastroenteritis vaccine - clostridium perfringens type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens type C toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Fowl pox vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - sordellii - perfringens types |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Escherichia coli antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bronchitis - bursal disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine virus diarrhea vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - hepatitis - parainfluenza - parvovirus vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - coronavirus - parainfluenza - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Streptococcus suis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - escherichia coli bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Haemophilus somnus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - moraxella bovis - campylobacter fetus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - measles - parainfluenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Corynebacterium pyogenes - escherichia coli - pasteurella multocida - salmonella typhimurium antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - hepatitis - parainfluenza - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - hepatitis - parainfluenza - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Fowl laryngotracheitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Toxoid (animal) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Actinobacillus pleuropneumoniae - erysipelothrix rhusiopathiae bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| hemorrhagic enteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Streptococcus equisimilis bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - novyi - sordellii - perfringens types C & D - haemophilus somnus bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mink enteritis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Leptospira bratislava bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - novyi - sordellii haemophilus somnus bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis vaccine - leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Porcine rotavirus - transmissible gastroenteritis vaccine - bordetella bronchiseptica - clostridium perfringens type C - erysipelothrix rhusiopathiae - escherichia coli - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| plasma animal normal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Escherichia coli antiserum and Pasteurella multocida antiserum and Salmonella typhimurium antiserum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Animal bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Corynebacterium pyogenes - pasteurella haemolytica - multocida antiserum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Toxin (animal) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - hepatitis - parainfluenza vaccine - leptospira bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Feline leukemia - rhinotracheitis - calici - panleukopenia - chlamydia psittaci vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - escherichia coli - pasteurella multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium haemolyticum bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Equine influenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - leptospira pomona bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - hepatitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Leptospira canicola/grippotyphosa/hardjo/icterohemorrhagiae/pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| mink distemper - enteritis vaccine - clostridium botulinum type C - pseudomonas aeruginosa bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Staphylococcus aureus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| ovine ecthyma vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - parainfluenza 3 vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Avian reovirus - bursal disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - parainfluenza 3 vaccine - leptospira pomona - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Actinobacillus pleuropneumoniae - bordetella bronchiseptica - erysipelothrix rhusiopathiae - haemophilus parasuis - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - measles - parainfluenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Product containing Escherichia coli antibody (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - measles vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - haemolyticum - novyi - tetani - perfringens types C & D bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis vaccine - leptospira pomona - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mink enteritis vaccine - clostridium botulinum type C - pseudomonas aeruginosa bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bordetella bronchiseptica - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - leptospira grippotyphosa - hardjo - pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Leptospira bratislava/canicola/grippotyphosa/hardjo/icterohemorrhagiae/pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Marek's disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine parainfluenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Actinobacillus pleuropneumoniae - bordetella bronchiseptica - erysipelothrix rhusiopathiae - pasteurella multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Streptococcus equi bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 vaccine - haemophilus somnus bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Mycobacterium cell wall fraction immunostimulant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii - perfringens types C & D - leptospira pomona - pasteurella haemolytica - multocida bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - respiratory syncytial virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Leptospira pomona bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium chauvoei - septicum - haemolyticum - novyi - sordellii bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Staphylococcus aureus bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium botulinum type C bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pasteurella multocida vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bovine rhinotracheitis - virus diarrhea - parainfluenza 3 - respiratory syncytial virus vaccine - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - pasteurella haemolytica bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Fox encephalitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Bursal disease - Newcastle disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Corynebacterium pyogenes - pasteurella haemolytica - multocida bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Erysipelothrix rhusiopathiae vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Clostridium perfringens types C & D - escherichia coli bacterin - toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - chlamydia psittaci - escherichia coli bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine parainfluenza - bordetella bronchiseptica vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Campylobacter fetus - leptospira canicola - grippotyphosa - hardjo - icterohaemorrhagiae - pomona - clostridium haemolyticum bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Haemophilus somnus - pasteurella haemolytica - multocida - salmonella typhimurium bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| sérum animal normal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pacheco's disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Avian paramyxovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Marble spleen disease vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine coronavirus - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Canine distemper - adenovirus type 2 - parainfluenza - parvovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| bronchitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
1 |
| Canine distemper - adenovirus type 2 - parainfluenza vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Escherichia coli - pasteurella haemolytica - multocida - salmonella typhimurium bacterin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
| Pasteurella multocida toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
vaccin |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]